Resiniferatoxin: The Evolution of the “Molecular Scalpel” for Chronic Pain Relief
Control of chronic pain is frequently inadequate or can be associated with debilitating side effects. Ablation of certain nociceptive neurons, while retaining all other sensory modalities and motor function, represents a new therapeutic approach to controlling severe pain while avoiding off-target s...
Main Author: | Dorothy Cimino Brown |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2016-08-01
|
Series: | Pharmaceuticals |
Subjects: | |
Online Access: | http://www.mdpi.com/1424-8247/9/3/47 |
Similar Items
-
Regulation of Pain Genes—Capsaicin vs Resiniferatoxin: Reassessment of Transcriptomic Data
by: Rajeev K. Singla, et al.
Published: (2020-10-01) -
Distribution, Morphological Characterization, and Resiniferatoxin-Susceptibility of Sensory Neurons That Innervate Rat Perirenal Adipose Tissue
by: Bo-Xun Liu, et al.
Published: (2019-03-01) -
Effects of Combination Treatment of Intravesical Resiniferatoxin Instillation and Hydrodistention in Patients with Refractory Painful Bladder Syndrome/Interstitial Cystitis: A Pilot Study
by: Byeong Kuk Ham, et al.
Published: (2012-03-01) -
Pain Treatment in the Companion Canine Model to Validate Rodent Results and Incentivize the Transition to Human Clinical Trials
by: Michael J. Iadarola, et al.
Published: (2021-08-01) -
Molecular Surgery Concept from Bench to Bedside: A Focus on TRPV1+ Pain-Sensing Neurons
by: László Pecze, et al.
Published: (2017-06-01)